Affymetrix Rolls Out OncoScan Service for Profiling FFPE Cancer Samples

CEO Kevin King said that the new service is "being used by many cancer centers around the world in population studies for the most challenging samples."

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.